NZ s Volpara buys Boston-based CRA Health for $25m
2 Feb, 2021 04:24 AM
2 minutes to read
NZ Herald
Wellington-based, ASX-listed heath technology firm Volpara has bought CRA Health, a US leader in breast cancer risk assessment, for US$18 million ($25m).
A further US$4m is payable upon CRA meeting of key performance and staff-retention targets.
Read More
Volpara said CRA is profitable, with annual recurring revenue of over US$4m ($6.2m).
The Boston-based company s software is integrated with the major electronic health record (EHR) and genetics companies, Volpara said.
Advertisement
Volpara s breast care platform assists in the delivery of personalised breast care, the company said.
Press release content from Wired Release. The AP news staff was not involved in its creation.
Global Automated Breast Ultrasound Systems (ABUS) Market Development Strategy, Future Plans and Industry Growth to 2031
January 14, 2021 GMT
Pune, Maharashtra, India, January 14 2021 (Wiredrelease) Prudour Pvt. Ltd :The research study on global Automated Breast Ultrasound Systems (ABUS) market presents an extensive analysis of current Automated Breast Ultrasound Systems (ABUS) trends, market size, drivers, Automated Breast Ultrasound Systems (ABUS) opportunities, challenges, and problems as well as key Automated Breast Ultrasound Systems (ABUS) market segments. Further, in the Automated Breast Ultrasound Systems (ABUS) market report,various definitions and classification of the Automated Breast Ultrasound Systems (ABUS) industry, applications and chain structure are discussed. In continuation with this data Automated Breast Ultrasound Systems (ABUS) report also covers the marketing strate